Breast Cancer

For women with human epidermal growth factor receptor type 2 (HER2)-positive early breast cancer, delaying trastuzumab until chemotherapy is completed may impair outcomes, according to findings from the landmark N9831 trial. The findings were presented by Edith Perez, MD, director of the Breast Cancer Program at the Mayo Clinic, Jacksonville, Florida.

For the prevention of skeletal-related events (SREs) in breast cancer patients with bone metastasis, denosumab proved superior to zoledronic acid (ZA) in a head-to-head randomized comparison conducted in 2048 women.

A medical center's redesigned lung cancer management protocol decreased both the time to diagnosis and the time from diagnosis to actual treatment to less than 20 days, according to a new study.

Oncology nurses who are involved in clinical trials should consider exposure in the "popular press" as a means of increasing patient recruitment, investigators said at the 32nd Annual Breast Cancer Symposium in San Antonio, Texas.

The discipline of breast surgery, like many specialties, has moved toward a minimally invasive approach to local therapy. Radical surgery had previously been the standard; however, surgical approaches continue to evolve as we gather more data about the oncologic safety of less invasive procedures. In addition, we are placing more emphasis on targeted therapy, and surgery is an integrated portion of patient care.

Page 18 of 18
Results 171 - 175 of 175